Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

esophageal cancer

  • Open Access
    Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, MIWHA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, JUNYA MORITA, ITARU HASHIMOTO, TETSUSHI ISHIGURO, ATSUSHI ONODERA, HARUHIKO CHO, KAZUYA ENDO, SHIZUNE ONUMA, KAZUKI KANO, KENTARO HARA, MOMOKO FUKUDA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo July 2022, 36 (4) 1896-1902; DOI: https://doi.org/10.21873/invivo.12909
  • Open Access
    The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
    TORU AOYAMA, MIWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, ATSUSHI ONODERA, JUNYA MORITA, ITARU HASHIMOTO, TETSUSHI ISHIGURO, KAZUYA ENDO, HARUHIKO CHO, SHIZUΝE ONUMA, MOMOKO FUKUDA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo July 2022, 36 (4) 1916-1922; DOI: https://doi.org/10.21873/invivo.12912
  • Open Access
    Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, DAISUKE MACHIDA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, KAZUKI KANO, KENTARO HARA, KENKI SEGAMI, ITARU HASHIMOTO, SHINSUKE NAGASAWA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo May 2022, 36 (3) 1424-1431; DOI: https://doi.org/10.21873/invivo.12847
  • You have access
    Paclitaxel and Carboplatin Versus Cisplatin and 5-Fluorouracil in Concurrent Chemoradiotherapy in Patients With Esophageal Cancer
    PO-HSU SU, SHUN-WEN HSUEH, CHEN-KAN TSENG, MING-MO HO, PO-JUNG SU, CHIA-YEN HUNG, KUN-YUN YEH, PEI-HUNG CHANG, YU-SHIN HUNG, YA-WEN HO, YU-CHING LIN and WEN-CHI CHOU
    In Vivo November 2021, 35 (6) 3391-3399; DOI: https://doi.org/10.21873/invivo.12638
  • You have access
    Low Preoperative Albumin-to-Globulin Ratio Is a Marker of Poor Prognosis in Patients With Esophageal Cancer
    YOSUKE ATSUMI, SHINNOSUKE KAWAHARA, SHO KAKUTA, ATSUSHI ONODERA, KENTARO HARA, KEISUKE KAZAMA, MASAKATSU NUMATA, TORU AOYAMA, AYAKO TAMAGAWA, HIROSHI TAMAGAWA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo November 2021, 35 (6) 3555-3561; DOI: https://doi.org/10.21873/invivo.12658
  • You have access
    A Meta-Analysis for Using Radiomics to Predict Complete Pathological Response in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiation
    YUNG-SHUO KAO and YEN HSU
    In Vivo May 2021, 35 (3) 1857-1863; DOI: https://doi.org/10.21873/invivo.12448
  • You have access
    Dosimetric Comparison Between Carbon-ion Radiotherapy and Photon Radiotherapy for Stage I Esophageal Cancer
    YOSUKE TAKAKUSAGI, DAISAKU YOSHIDA, YOHSUKE KUSANO, KIO KANO, WATARU ANNO, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, ITSUKO SERIZAWA, HIROYUKI KATOH, KOH IMURA, YOSHIKI TAKAYAMA, SHINICHI MINOHARA and TADASHI KAMADA
    In Vivo January 2021, 35 (1) 447-452; DOI: https://doi.org/10.21873/invivo.12277
  • You have access
    A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer
    TAKAFUMI SUZUKI, YUSUKE ISHIBASHI, HIRONORI TSUJIMOTO, SHINSUKE NOMURA, KEITA KOUZU, YUJIRO ITAZAKI, TAKAO SUGIHARA, MANABU HARADA, NOZOMI ITO, HIDEKAZU SUGASAWA, YOJI KISHI and HIDEKI UENO
    In Vivo November 2020, 34 (6) 3705-3711; DOI: https://doi.org/10.21873/invivo.12218
  • You have access
    The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, YOSUKE ATSUMI, SHINNOSUKE KAWAHARA, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIHIRO OZAWA, YUKIO MAEZAWA, KAZUKI KANO, MASAAKI MURAKAWA, KEISUKE KAZAMA, KENKI SEGAMI, KENTARO HARA, MASAKATSU NUMATA, TAKASHI OSHIMA, NORIO YUKAWA, MUNETAKA MASUDA and YASUSHI RINO
    In Vivo September 2020, 34 (5) 2783-2790; DOI: https://doi.org/10.21873/invivo.12103
  • You have access
    Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer
    YUSUKE ISHIBASHI, HIRONORI TSUJIMOTO, KEITA KOUZU, YUJIRO ITAZAKI, SATOSHI TSUCHIYA, SEIICHIRO FUJISHIMA, YOSHIHISA YAGUCHI, HIDEKAZU SUGASAWA, SHINSUKE NOMURA, NOZOMI ITO, MANABU HARADA, HIROMI NAGATA, EIJI SHINTO, YOJI KISHI and HIDEKI UENO
    In Vivo July 2020, 34 (4) 1941-1949; DOI: https://doi.org/10.21873/invivo.11991

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
In Vivo

© 2026 In Vivo

Powered by HighWire